Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to establish an IL-6 concentration cutoff and optimal time point(s) for using Symphony IL-6 that predict 28-day mortality in patients who are admitted or are int...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bluejay Diagnostics, Inc.
NCT06517810 · Acute Kidney Injury, Acute Kidney Injury Due to Sepsis
NCT07300306 · Sepsis, Septic Shock, and more
NCT07550400 · Septic Shock, Fluid Resuscitation
NCT06712641 · Sepsis
NCT07533994 · Sepsis
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Washington University of St. Louis
St Louis, Missouri
NewYork-Presbyterian Brooklyn Methodist Hospital
Brooklyn, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions